Lullaby
Lullaby, licence 80073998: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- EO Healing Ltd.
- NPN or DIN-HM
- 80073998
- Status
- Inactive licence
- Licence date
- 23 November 2016
- Revision date
- 13 March 2017
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cedrus atlantica Source : Bois | 1.0 % | Not calculated |
| Citrus bergamia Source : Pelure (fruit) | 0.5 % | Not calculated |
| Origanum majorana Source : Sommité en fleurs (herbe) | 0.33 % | Not calculated |
| Lavandula angustifolia Source : Sommité en fleurs (herbe) | 0.33 % | Not calculated |
| Chrysopogon zizanioides Source : Racine | 0.21 % | Not calculated |
| Chamaemelum nobile Source : Sommité | 0.17 % | Not calculated |
Non-medicinal ingredients
Huile de coco fractionnée, Huile essentielle de la feuille de Ravensara Aromatica
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Used in aromatherapy as a nervine/calmative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Do not expose the applied area(s) to the sun for 24 to 48 hours after application.
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80073998
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.